Ignite Creation Date:
2024-05-06 @ 3:19 PM
Last Modification Date:
2024-10-26 @ 1:47 PM
Study NCT ID:
NCT04596657
Status:
COMPLETED
Last Update Posted:
2023-12-08
First Post:
2020-10-15
Brief Title:
Vitamin D3 Supplementation to Prevent Respiratory Tract Infections
Sponsor:
The Cooper Health System
Organization:
The Cooper Health System
Study Overview
Official Title:
Vitamin D3 Supplementation to Prevent Respiratory Tract Infections Including Covid-19 in Hospital Workers a Pragmatic Study
Status:
COMPLETED
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The Cooper vitamin D3 study is a randomized study investigating whether daily vitamin D3 supplementation can prevent respiratory tract infections influenza-like illness and covid-19 in hospital workers
Detailed Description:
Influenza-like illness and covid-19 were added to this summary because the protocol uses respiratory tract infections and influenza-like illness interchangeably Influenza-like illness is more accurate
Protocol amendments
Protocol title was amended to include covid-19 Minimum age was changed from 52 to 18 expanding the sample size Exclusion criteria re vitamin D intake was changed from 5000 to 5000 IU
Protocol amendments
Protocol title was amended to include covid-19 Minimum age was changed from 52 to 18 expanding the sample size Exclusion criteria re vitamin D intake was changed from 5000 to 5000 IU
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None